| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56666880a5e2b7703e98a4f9b2d9daf6 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-42 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42 |
| filingDate |
2001-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5d66b5c333663d6c0acaf5e50ae83c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba76c5be99f9195a6b7c747dc813f686
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_923c42b4d5c147a869885691d5165200 |
| publicationDate |
2001-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2001027204-A1 |
| titleOfInvention |
Use of amino-isoxazolidone compounds for improvement of implicit memory |
| abstract |
A class of amino-isoxazolidone compounds is described for use to improve implicit memory in patients susceptible to or afflicted with Alzheimer's Disease. Preferred compounds of this class are D-cycloserine and its prodrugs. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004208923-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11024329-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7750030-B2 |
| priorityDate |
1994-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |